BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naqvi S, Panghal A, Flora SJS. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Front Neurosci 2020;14:494. [PMID: 32581676 DOI: 10.3389/fnins.2020.00494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Faouzi A, Roullin VG. Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases. Pharmaceuticals (Basel) 2021;14:109. [PMID: 33573213 DOI: 10.3390/ph14020109] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Male D, Gromnicova R. Nanocarriers for Delivery of Oligonucleotides to the CNS. Int J Mol Sci 2022;23:760. [PMID: 35054957 DOI: 10.3390/ijms23020760] [Reference Citation Analysis]
3 Wu WC, Song SJ, Zhang Y, Li X. Role of Extracellular Vesicles in Autoimmune Pathogenesis. Front Immunol 2020;11:579043. [PMID: 33072123 DOI: 10.3389/fimmu.2020.579043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
4 Almeida Furquim de Camargo B, Fonseca-santos B, Gonçalves Carvalho S, Corrêa Carvalho G, Delello Di Filippo L, Sousa Araújo VH, Lobato Duarte J, Polli Silvestre AL, Bauab TM, Chorilli M. Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases. Critical Reviews in Microbiology. [DOI: 10.1080/1040841x.2022.2047007] [Reference Citation Analysis]
5 Wu D, Fei F, Zhang Q, Wang X, Gong Y, Chen X, Zheng Y, Tan B, Xu C, Xie H, Fang W, Chen Z, Wang Y. Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy. Sci Adv 2022;8:eabm3381. [PMID: 35020438 DOI: 10.1126/sciadv.abm3381] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cunha A, Gaubert A, Latxague L, Dehay B. PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases. Pharmaceutics 2021;13:1042. [PMID: 34371733 DOI: 10.3390/pharmaceutics13071042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mutingwende FP, Kondiah PPD, Ubanako P, Marimuthu T, Choonara YE. Advances in Nano-Enabled Platforms for the Treatment of Depression. Polymers (Basel) 2021;13:1431. [PMID: 33946703 DOI: 10.3390/polym13091431] [Reference Citation Analysis]
8 Jayanti S, Moretti R, Tiribelli C, Gazzin S. Bilirubin: A Promising Therapy for Parkinson's Disease. Int J Mol Sci 2021;22:6223. [PMID: 34207581 DOI: 10.3390/ijms22126223] [Reference Citation Analysis]
9 Kaya M, Ahishali B. Basic physiology of the blood-brain barrier in health and disease: a brief overview. Tissue Barriers 2021;9:1840913. [PMID: 33190576 DOI: 10.1080/21688370.2020.1840913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 More SK, Pawar AP. Preparation, optimization and preliminary pharmacokinetic study of curcumin encapsulated turmeric oil microemulsion in zebra fish. Eur J Pharm Sci 2020;155:105539. [PMID: 32898637 DOI: 10.1016/j.ejps.2020.105539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Machhi J, Yeapuri P, Markovic M, Patel M, Yan W, Lu Y, Cohen JD, Hasan M, Abdelmoaty MM, Zhou Y, Xiong H, Wang X, Mosley RL, Gendelman HE, Kevadiya BD. Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis. ACS Chem Neurosci 2022;13:1232-44. [PMID: 35312284 DOI: 10.1021/acschemneuro.1c00847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kumar G, Virmani T, Pathak K, Alhalmi A, Panakanti R. A Revolutionary Blueprint for Mitigation of Hypertension via Nanoemulsion. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4109874] [Reference Citation Analysis]
13 Calzoni E, Cesaretti A, Montegiove N, Di Michele A, Pellegrino RM, Emiliani C. HexA-Enzyme Coated Polymer Nanoparticles for the Development of a Drug-Delivery System in the Treatment of Sandhoff Lysosomal Storage Disease. JFB 2022;13:37. [DOI: 10.3390/jfb13020037] [Reference Citation Analysis]
14 Zhu FD, Hu YJ, Yu L, Zhou XG, Wu JM, Tang Y, Qin DL, Fan QZ, Wu AG. Nanoparticles: A Hope for the Treatment of Inflammation in CNS. Front Pharmacol 2021;12:683935. [PMID: 34122112 DOI: 10.3389/fphar.2021.683935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Naki T, Aderibigbe BA. Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer. Pharmaceutics 2022;14:1048. [DOI: 10.3390/pharmaceutics14051048] [Reference Citation Analysis]
16 Jafari Z, Bigham A, Sadeghi S, Dehdashti SM, Rabiee N, Abedivash A, Bagherzadeh M, Nasseri B, Karimi-Maleh H, Sharifi E, Varma RS, Makvandi P. Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications. J Med Chem 2021. [PMID: 34919379 DOI: 10.1021/acs.jmedchem.1c01144] [Reference Citation Analysis]
17 Akyuz E, Paudel YN, Polat AK, Dundar HE, Angelopoulou E. Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities. Epilepsy Behav 2021;115:107701. [PMID: 33412369 DOI: 10.1016/j.yebeh.2020.107701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Gosselet F, Loiola RA, Roig A, Rosell A, Culot M. Central nervous system delivery of molecules across the blood-brain barrier. Neurochem Int 2021;144:104952. [PMID: 33400964 DOI: 10.1016/j.neuint.2020.104952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Park CY, Seo H, Lee EH, Han M, Choi H, Park KS, Yoon SY, Chang SH, Park J. Verification of Blood-Brain Barrier Disruption Based on the Clinical Validation Platform Using a Rat Model with Human Skull. Brain Sci 2021;11:1429. [PMID: 34827428 DOI: 10.3390/brainsci11111429] [Reference Citation Analysis]
20 Cunha A, Gaubert A, Verget J, Thiolat M, Barthélémy P, Latxague L, Dehay B. Trehalose-Based Nucleolipids as Nanocarriers for Autophagy Modulation: An In Vitro Study. Pharmaceutics 2022;14:857. [DOI: 10.3390/pharmaceutics14040857] [Reference Citation Analysis]
21 Jiang P, Gan M, Yen SH, Dickson DW. Nanoparticles With Affinity for α-Synuclein Sequester α-Synuclein to Form Toxic Aggregates in Neurons With Endolysosomal Impairment. Front Mol Neurosci 2021;14:738535. [PMID: 34744624 DOI: 10.3389/fnmol.2021.738535] [Reference Citation Analysis]
22 Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Séguy L, Groo A, Malzert-fréon A. How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment? Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.02.022] [Reference Citation Analysis]
24 Khan J, Rudrapal M, Bhat EA, Ali A, Alaidarous M, Alshehri B, Banwas S, Ismail R, Egbuna C. Perspective Insights to Bio-Nanomaterials for the Treatment of Neurological Disorders. Front Bioeng Biotechnol 2021;9:724158. [PMID: 34712651 DOI: 10.3389/fbioe.2021.724158] [Reference Citation Analysis]
25 Perrelli A, Fatehbasharzad P, Benedetti V, Ferraris C, Fontanella M, De Luca E, Moglianetti M, Battaglia L, Retta SF. Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opin Drug Deliv 2021;18:849-76. [PMID: 33406376 DOI: 10.1080/17425247.2021.1873273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Goel H, Kalra V, Verma SK, Dubey SK, Tiwary AK. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. J Control Release 2021;341:782-811. [PMID: 34906605 DOI: 10.1016/j.jconrel.2021.12.009] [Reference Citation Analysis]
27 Omer AM, Ziora ZM, Tamer TM, Khalifa RE, Hassan MA, Mohy-Eldin MS, Blaskovich MAT. Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin. Molecules 2021;26:449. [PMID: 33467056 DOI: 10.3390/molecules26020449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
28 Sreeharsha N, Chitrapriya N, Jang YJ, Kenchappa V. Evaluation of nanoparticle drug-delivery systems used in preclinical studies. Ther Deliv 2021;12:325-36. [PMID: 33759568 DOI: 10.4155/tde-2020-0116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Abdelwahab GM, Mira A, Cheng YB, Abdelaziz TA, Lahloub MFI, Khalil AT. Acetylcholine esterase inhibitory activity of green synthesized nanosilver by naphthopyrones isolated from marine-derived Aspergillus niger. PLoS One 2021;16:e0257071. [PMID: 34506550 DOI: 10.1371/journal.pone.0257071] [Reference Citation Analysis]
30 Zapolnik P, Pyrkosz A. Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I-A Mini-Review. Int J Mol Sci 2022;23:4785. [PMID: 35563175 DOI: 10.3390/ijms23094785] [Reference Citation Analysis]
31 Sgambato A, Pastori V, Russo L, Vesentini S, Lecchi M, Cipolla L. Neoglycosylated Collagen: Effect on Neuroblastoma F-11 Cell Lines. Molecules 2020;25:E4361. [PMID: 32977424 DOI: 10.3390/molecules25194361] [Reference Citation Analysis]
32 Dai Y, Song Y, Xie J, Xiao G, Li X, Li Z, Gao F, Zhang Y, He E, Xu S, Wang Y, Zheng W, Jiang X, Qi Z, Meng D, Fan Z, Cai X. CB1-Antibody Modified Liposomes for Targeted Modulation of Epileptiform Activities Synchronously Detected by Microelectrode Arrays. ACS Appl Mater Interfaces 2020;12:41148-56. [PMID: 32809788 DOI: 10.1021/acsami.0c13372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Padmanabhan P, Palanivel M, Kumar A, Máthé D, Radda GK, Lim KL, Gulyás B. Nanotheranostic agents for neurodegenerative diseases. Emerg Top Life Sci 2020;4:645-75. [PMID: 33320185 DOI: 10.1042/ETLS20190141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang F, Moen DR, Sauni C, Kan SH, Li S, Le SQ, Lomenick B, Zhang X, Ekins S, Singamsetty S, Wood J, Dickson PI, Chou TF. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice. Mol Pharm 2021;18:214-27. [PMID: 33320673 DOI: 10.1021/acs.molpharmaceut.0c00831] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kamali Shahri SM, Sharifi S, Mahmoudi M. Interdependency of influential parameters in therapeutic nanomedicine. Expert Opin Drug Deliv 2021;:1-15. [PMID: 33887999 DOI: 10.1080/17425247.2021.1921732] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Zoey FL, Palanivel M, Padmanabhan P, Gulyás B. Parkinson's Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation. Front Cell Dev Biol 2021;9:707441. [PMID: 34490255 DOI: 10.3389/fcell.2021.707441] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Anand U, Carpena M, Kowalska-Góralska M, Garcia-Perez P, Sunita K, Bontempi E, Dey A, Prieto MA, Proćków J, Simal-Gandara J. Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective. Sci Total Environ 2022;821:153472. [PMID: 35093375 DOI: 10.1016/j.scitotenv.2022.153472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
38 Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone MAB. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 2021;13:1897. [PMID: 34834311 DOI: 10.3390/pharmaceutics13111897] [Reference Citation Analysis]